Literature DB >> 15824913

Interaction between mivacurium and pancuronium: impact of the order of administration.

C Motamed1, K Kirov, X Combes, P Feiss, P Duvaldestin.   

Abstract

INTRODUCTION: Potentiation of mivacurium by low-dose pancuronium is mostly due to an inhibition of plasma butyryl cholinesterase (BchE) resulting in a decreased rate of hydrolysis of mivacurium. Nevertheless, an interaction at the receptor site could not be ruled out. By changing the order of the muscle relaxant injections, we may lessen the pharmacokinetic interaction and assess the impact at the acetylcholine receptor level.
METHODS: Twenty patients scheduled for general anesthesia with propofol and fentanyl, and isoflurane were randomized into two groups receiving, mivacurium 100 microg kg-1 followed by pancuronium 15 microg kg-1 (group 1) or pancuronium 15 microg kg-1 followed by mivacurium 100 microg kg-1 (group 2). BchE before and after injection of each relaxant was measured. Neuromuscular block was assessed with a force transducer at the adductor pollicis measuring the elicited twitch to ulnar nerve stimulation.
RESULTS: The neuromuscular block was greater when pancuronium was administered before mivacurium (100% versus 96+/-3%; P<0.05). Times to recovery of the elicited twitch response to 25% and 75% of control value were increased by 100% (P<0.05). After pancuronium, decreases in BchE of 11% and 14% in groups 1 and 2 were observed, respectively.
CONCLUSION: Interaction between mivacurium and low dose pancuronium is significant only when mivacurium is injected after pancuronium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15824913     DOI: 10.1007/s00228-005-0905-x

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  The mechanism of pancuronium potentiation of mivacurium block: use of the isolated-arm technique.

Authors:  C Motamed; K Kirov; T Lieutaud; P Duvaldestin
Journal:  Anesth Analg       Date:  2000-09       Impact factor: 5.108

2.  Mivacurium when preceded by pancuronium becomes a long-acting muscle relaxant.

Authors:  O Erkola; P Rautoma; O A Meretoja
Journal:  Anesthesiology       Date:  1996-03       Impact factor: 7.892

3.  Screening patients with prolonged neuromuscular blockade after succinylcholine and mivacurium.

Authors:  Charles Cerf; Martine Mesguish; Inanna Gabriel; Serge Amselem; Philippe Duvaldestin
Journal:  Anesth Analg       Date:  2002-02       Impact factor: 5.108

4.  Rocuronium-mivacurium combination is synergistic.

Authors:  M Naguib
Journal:  Anaesthesia       Date:  1997-09       Impact factor: 6.955

5.  Interactions between mivacurium and pancuronium.

Authors:  S Kim; J C Shim; D W Kim
Journal:  Br J Anaesth       Date:  1997-07       Impact factor: 9.166

6.  Pharmacokinetics of mivacurium isomers and their metabolites in healthy volunteers after intravenous bolus administration.

Authors:  M Lacroix; F Donati; F Varin
Journal:  Anesthesiology       Date:  1997-02       Impact factor: 7.892

7.  Neuromuscular and cardiovascular advantages of combinations of mivacurium and rocuronium over either drug alone.

Authors:  S Y Kim; M H Cho
Journal:  Anaesthesia       Date:  1996-10       Impact factor: 6.955

8.  Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia.

Authors:  D W Kim; G P Joshi; P F White; E R Johnson
Journal:  Anesth Analg       Date:  1996-10       Impact factor: 5.108

9.  Duration of the pharmacodynamic interaction between pancuronium and mivacurium.

Authors:  M Beaussier; H Deriaz; A De Traverse; Z Abdelhalim; A Lienhart
Journal:  Br J Anaesth       Date:  1998-08       Impact factor: 9.166

10.  Identification of human plasma cholinesterase variants in 6,688 individuals using biochemical analysis.

Authors:  F S Jensen; L T Skovgaard; J Viby-Mogensen
Journal:  Acta Anaesthesiol Scand       Date:  1995-02       Impact factor: 2.105

View more
  3 in total

1.  Dose-response effect of serum butyrylcholinesterase activity after clinical doses of pancuronium.

Authors:  C Motamed; P Fanen; P Feiss; K Kirov; P Duvaldestin
Journal:  Eur J Clin Pharmacol       Date:  2008-09-03       Impact factor: 2.953

2.  Synergy between pairs of competitive antagonists at adult human muscle acetylcholine receptors.

Authors:  Man Liu; James P Dilger
Journal:  Anesth Analg       Date:  2008-08       Impact factor: 5.108

3.  The effect of defasciculating doses of pancuronium and atracurium on succinylcholine neuromuscular blockade.

Authors:  Cyrus Motamed; Duvaldestin Philippe
Journal:  Anesth Pain Med       Date:  2014-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.